Biological
Pentavac clinical trials
- studies test it
- 12
- open now
- 1
- in phase 3
- 7
- first study started
- 2003
Keep track of what changes. Save the Pentavac studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2014 | 1 |
| 2018 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 1
- Phase 3
- 7
- Phase 4
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 2
Sanofi (7) · Sanofi Pasteur, a Sanofi Company (3) · PATH (1) · Institute of Medical Biology, Chinese Academy of Medical Sciences (1)
Often tested with
Tested in the same studies.
Meningococcal Vaccines (1) · Hepatitis B Vaccines (1) · RotaTeq (1) · DTaP-IPV-HB-PRP-T vaccine (1) · PHiD-CV vaccine (1)
Studies
Open first, then newest update. How each study uses Pentavac is read from its arms, and is right about nine times in ten.
Testing it · 12
- Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined VaccineRecruitingPhase 1Institute of Medical Biology, Chinese Academy of Medical SciencesNCT06184542Written as PENTAXIM (one-dose booster)
- Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and MexicoCompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT03630705Written as Diphtheria, Tetanus, Pertussis (Acellular, Component) Poliomyelitis (inactivated) Vaccine, and Haemophilus influenza type b Conjugate Vaccine
- Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy ToddlersCompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT01411241Written as DTaP IPV//Hib vaccine
- Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and ToddlersCompletedPhase 1/2PATHNCT02097472Written as Pentavac
- Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in ChinaCompletedPhase 4Sanofi Pasteur, a Sanofi CompanyNCT01491087Written as DTacP IPV//PRP~T combined vaccine: PENTAXIM®
- Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean InfantsCompletedPhase 3SanofiNCT00303316Written as DTaP-IPV//PRP~T combined vaccine
- Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.CompletedPhase 3SanofiNCT01214889Written as PENTAXIM™: DTacP IPV//PRP~T combined vaccine
- Immunogenicity and Safety of Pentaxim in South African InfantsCompletedPhase 3SanofiNCT00254969Written as Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib
- Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 MonthsCompletedPhase 3SanofiNCT00453570Written as Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib
- Assessment of the Immunogenicity and Safety of PENTAXIM™ in PhilippinesCompletedPhase 4SanofiNCT00254917Written as Diphteria, Tetanus, Polio, Acellular Pertussis, Hib vaccine
- Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in ThailandCompletedPhase 4SanofiNCT00255021Written as Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib Vac
- Immunogenicity and Safety of Pentaxim™ in an Indian PopulationCompletedPhase 3SanofiNCT00259337Written as Diphteria/Tetanus/Polio/Acellular Pertussis/Hib vaccine
Given in every arm · 2 — Pentavac is usual care beside what is tested
- Study Comparing DTP-HB-Hib by Disposable-Syringe Jet Injector To Vaccination By Needle And Syringe In InfantsTerminatedPhase 4Serum Institute of India Pvt. Ltd.NCT02409095Written as DTP-HB-Hib vaccine
- Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in InfantsCompletedPhase 3Wyeth is now a wholly owned subsidiary of PfizerNCT00366678Written as Pentavac
As the comparator · 4 — what is tested is compared with Pentavac
- A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, AdsorbedActive, not recruitingPhase 3China National Biotec Group Company LimitedNCT05091619Written as Diphtheria,tetanus,pertussis(acellular,component),poliomyelitis(inactivated) vaccine(absorbed) and Haemophilus influenzae type b conjugate vaccine
- DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed InfantsCompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT02094833Written as DTaP-IPV//PRP~T and Hepatitis B vaccine
- Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months ScheduleCompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT00315055Written as DTaP-IPV//PRP~T combined
- Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean InfantsCompletedPhase 2Sanofi Pasteur, a Sanofi CompanyNCT00831311Written as DTaP-IPV//PRP~T combined vaccine & Recombinant hep B vaccine